ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $768,000 | +32.0% | 208,587 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $582,000 | -22.8% | 205,487 | +1.1% | 0.00% | 0.0% |
| Q1 2018 | $754,000 | +20.6% | 203,287 | +163.3% | 0.00% | 0.0% |
| Q3 2016 | $625,000 | -44.6% | 77,208 | -46.6% | 0.00% | -50.0% |
| Q2 2016 | $1,128,000 | +2.1% | 144,608 | +1.1% | 0.00% | 0.0% |
| Q1 2016 | $1,105,000 | -17.8% | 143,100 | +14.8% | 0.00% | -33.3% |
| Q4 2015 | $1,344,000 | +53.6% | 124,600 | -1.7% | 0.00% | +50.0% |
| Q3 2015 | $875,000 | +135.8% | 126,700 | +179.1% | 0.00% | +100.0% |
| Q2 2013 | $371,000 | – | 45,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |